Onnit

Total Mitochondria

D
N+ Score60
Longevity & NAD+Serving: 1 Capsule(s)Type: Non-Nutrient/Non-Botanical

Onnit Total Mitochondria is a longevity and NAD+ category supplement designed to support mitochondrial function, featuring three active ingredients: MicroActive Resveratrol at 167 mg, MicroActive CoQ10 at 120 mg, and MicroPQQ at 40 mg. This product holds an N+ Score of 60, resulting in a 'D' grade, placing it in the average tier. While the label transparency is excellent at 100%, the formula completeness and ingredient adequacy are rated at 25% and 50% respectively, suggesting that some ingredient dosages may not reach commonly studied clinical levels for their intended benefits. With a total of 3 ingredients, this supplement offers a targeted approach, but research on the specific forms and dosages provided may vary. It may appeal to individuals interested in mitochondrial support with specific forms of resveratrol, CoQ10, and PQQ.

About This Product

Total Mitochondria by Onnit is a longevity & nad+ supplement containing 3 active ingredients. It has earned an N+ Score of 60/100 (Grade D).

N+ Score Breakdown

Ingredient Adequacy50/100

Are key ingredients present at clinically effective doses based on research?

Formula Completeness25/100

Does the product include all expected ingredients for its supplement category?

Label Transparency100/100

Are individual ingredient amounts clearly disclosed without proprietary blends?

Ingredient Diversity83/100

Does the formula include a breadth of beneficial compounds from multiple pathways?

Strengths

  • +Fully transparent label with individual ingredient amounts disclosed
  • +Broad ingredient diversity exceeding category norms

Weaknesses

  • Missing several expected ingredients for its category

Ingredient Analysis (3 ingredients)

IngredientAmountDose Adequacy
MicroActive Resveratrol167.000 mgN/A
MicroActive CoQ10120.000 mgN/A
MicroPQQ40.000 mgN/A

Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.